186 related articles for article (PubMed ID: 31138874)
1. Encapsulation of a TRPM8 Agonist, WS12, in Lipid Nanocapsules Potentiates PC3 Prostate Cancer Cell Migration Inhibition through Channel Activation.
Grolez GP; Hammadi M; Barras A; Gordienko D; Slomianny C; Völkel P; Angrand PO; Pinault M; Guimaraes C; Potier-Cartereau M; Prevarskaya N; Boukherroub R; Gkika D
Sci Rep; 2019 May; 9(1):7926. PubMed ID: 31138874
[TBL] [Abstract][Full Text] [Related]
2. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
Ma S; G G; Ak VE; Jf D; H H
Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
[TBL] [Abstract][Full Text] [Related]
3. Menthol evokes Ca
Nazıroğlu M; Blum W; Jósvay K; Çiğ B; Henzi T; Oláh Z; Vizler C; Schwaller B; Pecze L
Redox Biol; 2018 Apr; 14():439-449. PubMed ID: 29078169
[TBL] [Abstract][Full Text] [Related]
4. TRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration.
Grolez GP; Gordiendko DV; Clarisse M; Hammadi M; Desruelles E; Fromont G; Prevarskaya N; Slomianny C; Gkika D
Cell Death Dis; 2019 Sep; 10(9):652. PubMed ID: 31501416
[TBL] [Abstract][Full Text] [Related]
5. PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Gkika D; Flourakis M; Lemonnier L; Prevarskaya N
Oncogene; 2010 Aug; 29(32):4611-6. PubMed ID: 20531306
[TBL] [Abstract][Full Text] [Related]
6. Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.
Wang Y; Wang X; Yang Z; Zhu G; Chen D; Meng Z
Pathol Oncol Res; 2012 Oct; 18(4):903-10. PubMed ID: 22437241
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines.
Okamoto Y; Ohkubo T; Ikebe T; Yamazaki J
Int J Oncol; 2012 May; 40(5):1431-40. PubMed ID: 22267123
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.
Valero M; Morenilla-Palao C; Belmonte C; Viana F
Pflugers Arch; 2011 Jan; 461(1):99-114. PubMed ID: 21052713
[TBL] [Abstract][Full Text] [Related]
9. Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells.
Kim SH; Nam JH; Park EJ; Kim BJ; Kim SJ; So I; Jeon JH
Biochim Biophys Acta; 2009 Jan; 1792(1):33-8. PubMed ID: 18955132
[TBL] [Abstract][Full Text] [Related]
10. TRPM8 as an Anti-Tumoral Target in Prostate Cancer Growth and Metastasis Dissemination.
Grolez GP; Chinigò G; Barras A; Hammadi M; Noyer L; Kondratska K; Bulk E; Oullier T; Marionneau-Lambot S; Le Mée M; Rétif S; Lerondel S; Bongiovanni A; Genova T; Roger S; Boukherroub R; Schwab A; Fiorio Pla A; Gkika D
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743115
[TBL] [Abstract][Full Text] [Related]
11. Characterization of selective TRPM8 ligands and their structure activity response (S.A.R) relationship.
Sherkheli MA; Vogt-Eisele AK; Bura D; Beltrán Márques LR; Gisselmann G; Hatt H
J Pharm Pharm Sci; 2010; 13(2):242-53. PubMed ID: 20816009
[TBL] [Abstract][Full Text] [Related]
12. The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel.
Babes RM; Selescu T; Domocos D; Babes A
Toxicol Appl Pharmacol; 2017 Dec; 336():55-65. PubMed ID: 29054683
[TBL] [Abstract][Full Text] [Related]
13. Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.
Alaimo A; Lorenzoni M; Ambrosino P; Bertossi A; Bisio A; Macchia A; Zoni E; Genovesi S; Cambuli F; Foletto V; De Felice D; Soldovieri MV; Mosca I; Gandolfi F; Brunelli M; Petris G; Cereseto A; Villarroel A; Thalmann G; Carbone FG; Kruithof-de Julio M; Barbareschi M; Romanel A; Taglialatela M; Lunardi A
Cell Death Dis; 2020 Dec; 11(12):1039. PubMed ID: 33288740
[TBL] [Abstract][Full Text] [Related]
14. The role of TRPM8 in the Guinea-pig bladder-cooling reflex investigated using a novel TRPM8 antagonist.
Gardiner JC; Kirkup AJ; Curry J; Humphreys S; O'Regan P; Postlethwaite M; Young KC; Kitching L; Ethell BT; Winpenny D; McMurray G
Eur J Pharmacol; 2014 Oct; 740():398-409. PubMed ID: 25058909
[TBL] [Abstract][Full Text] [Related]
15. Involvement of TRPM8 Channel in Radiation-Induced DNA Damage Repair Mechanism Contributing to Radioresistance of B16 Melanoma.
Nomura D; Abe R; Tsukimoto M
Biol Pharm Bull; 2021 May; 44(5):642-652. PubMed ID: 33658452
[TBL] [Abstract][Full Text] [Related]
16. TRPM8 and prostate: a cold case?
Noyer L; Grolez GP; Prevarskaya N; Gkika D; Lemonnier L
Pflugers Arch; 2018 Oct; 470(10):1419-1429. PubMed ID: 29926226
[TBL] [Abstract][Full Text] [Related]
17. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
Denda M; Tsutsumi M; Denda S
Exp Dermatol; 2010 Sep; 19(9):791-5. PubMed ID: 20636355
[TBL] [Abstract][Full Text] [Related]
18. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.
Bidaux G; Flourakis M; Thebault S; Zholos A; Beck B; Gkika D; Roudbaraki M; Bonnal JL; Mauroy B; Shuba Y; Skryma R; Prevarskaya N
J Clin Invest; 2007 Jun; 117(6):1647-57. PubMed ID: 17510704
[TBL] [Abstract][Full Text] [Related]
19. TRPM8 has a key role in experimental colitis-induced visceral hyperalgesia in mice.
Hosoya T; Matsumoto K; Tashima K; Nakamura H; Fujino H; Murayama T; Horie S
Neurogastroenterol Motil; 2014 Aug; 26(8):1112-21. PubMed ID: 24832648
[TBL] [Abstract][Full Text] [Related]
20. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators.
Beck B; Bidaux G; Bavencoffe A; Lemonnier L; Thebault S; Shuba Y; Barrit G; Skryma R; Prevarskaya N
Cell Calcium; 2007 Mar; 41(3):285-94. PubMed ID: 16949669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
